Skip to content
REPORT (2025/2139(INI))

On the implementation of Europe’s Beating Cancer Plan

A-10-2026-0261

Committee on Public Health · Rapporteur: Vlad VasileVoiculescu

✦ In short · AI summary of this text, generated 6 Nov 2026

Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.

Parliament's resolution assesses the implementation of Europe's Beating Cancer Plan and calls for the next phase to focus on outcomes, not process. It asks for dedicated, predictable funding in the 2028-2034 multiannual financial framework, including at least EUR 2.5 billion for cancer within EU4Health. It demands action on prevention: a revised Tobacco Products Directive, health warnings on alcohol, nutrition measures and higher HPV vaccination coverage. It calls for stronger screening, AI-supported detection, better access to treatment and cross-border care, and measures on inequalities, children and survivors. It proposes annual reporting to Parliament's Committee on Public Health against key performance indicators and an independent scoreboard. It finds that over 90 % of the Plan's actions were launched but that outcome measurement is lacking.

Committee position. The Committee on Public Health proposes that Parliament adopt the resolution, welcoming the Plan but calling for outcome-based monitoring, dedicated funding, stronger prevention and screening, and annual accountability to Parliament.

Key points

  1. Welcomes the Plan as a framework covering the whole cancer pathway and calls for a 'Health in All Policies' approach across EU policies.
  2. Notes that more than 90 % of actions are concluded or ongoing but regrets that measurement is based on process completion rather than health outcomes.
  3. Calls for an outcome-based monitoring framework with baselines, time-bound targets and comparable indicators broken down by Member State and region.
  4. Expresses concern at the EUR 1 billion cut to EU4Health and calls for EUR 10.05 billion for EU4Health priorities, with at least EUR 2.5 billion for cancer.
  5. Calls for a revised Tobacco Products Directive covering all tobacco and nicotine products, updated advertising rules, higher minimum excise duties and pre-market health impact assessments.
  6. Calls for mandatory health-related information on alcoholic beverages, a revised EU alcohol strategy and measures to reduce alcohol marketing to minors.
  7. Calls for a mandatory harmonised EU front-of-pack nutritional label, action on ultra-processed foods and healthy diets from childhood.
  8. Regrets that the 90 % screening target for 2025 was not met and calls for organised population-based screening, AI tools that are clinically validated, and common follow-up indicators.
  9. Calls for equitable access to cancer medicines and innovative therapies, joint procurement, streamlined cross-border reimbursement and full use of EUDAMED.
  10. Calls for action on inequalities, the gender dimension, children and young adults, and survivors, including the 'Right to Be Forgotten' and fertility preservation.
  11. Calls for a structured annual dialogue in which the Commission reports to Parliament's Committee on Public Health against key performance indicators disaggregated by Member State.
  12. Calls for at least EUR 2.5 billion for the Plan in the 2028-2034 multiannual financial framework and a shift from input-based grants to outcome-linked delivery.

Who is affected

  • Member states: asked to update national cancer control plans, expand screening and vaccination, and address inequalities.
  • The Commission: asked to propose revised tobacco and alcohol rules, a monitoring framework and annual reporting.
  • Cancer patients and survivors: measures on access to treatment, cross-border care, reintegration and financial protection.
  • Healthcare professionals: calls on workforce planning, training, AI literacy and action on shortages and burnout.
  • Children, adolescents and young adults with cancer: calls for access to trials, cross-border referral and tailored services.

Figures and deadlines

  • EUR 4 billion allocated to the Plan, with 49.4 % for prevention, 24.9 % for screening, 13.9 % for treatment, 6.8 % for quality of life and 4.6 % for inequalities.
  • EUR 1 billion cut in funding for EU4Health.
  • EUR 10.05 billion in current prices called for EU4Health priorities, with a minimum of EUR 2.5 billion for cancer-related actions.
  • 898 cancer-focused projects, including 61 Cancer Mission projects, selected for a total of EUR 2.086 billion.
  • 90 % of the target population to be offered breast, cervical and colorectal cancer screening by 2025; the objective has not been met.
  • 90 % of eligible patients to have access to national Comprehensive Cancer Centres by 2030.
  • No less than EUR 2.5 billion earmarked for the Plan in the 2028-2034 multiannual financial framework.
  • Screening rates range from below 10 % to above 90 % across the EU.

Legal basis: Articles 168 and 191 of the Treaty on the Functioning of the European Union.